Evotec — Just – Evotec Biologics
Tracked across 2 events · 13 articles · First seen Jun 30, 2026 · Last active Sep 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Evotec — Just – Evotec Biologics, a wholly-owned subsidiary of Evotec SE, is the direct developer and provider of the J.TRAIN platform, which represents a strategic shift towards a capital-lighter and technology-focused business model for the company.
Jun 30, 2026 · 7 articles
Business
Evotec SE announced the initiation of a Phase 1 clinical trial for JST-018, a cocktail of investigational monoclonal antibodies targeting orthopoxviruses, developed by its subsidiary Evotec — Just – Evotec Biologics under the U.S. Department…
Impact: As the developer and manufacturer, Evotec — Just – Evotec Biologics achieved a key milestone, validating its continuous manufacturing platform and strengthening its portfolio of government contracts.
Sep 09, 2026 · 6 articles
80
Evotec — Just – Evotec Biologics manufactured clinical trial materialEvotec Phase 1...
ERGEN INTELLIGENCE
Track Evotec — Just – Evotec Biologics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard